Dr. Cigarroa to head state panel on kidney disease

December 23, 2019
 

Renowned transplant surgeon and former UT System chancellor Francisco G. Cigarroa, M.D., has been appointed chairman of the Chronic Kidney Disease Task Force of the state of Texas. Also, Kumar Sharma, M.D., chief of the Division of Nephrology and vice chair of research in the Department of Medicine at UT Health San Antonio, was named […]


Picture of Francisco G. Cigarroa, M.D.

Dr. Cigarroa to head state panel on kidney disease

December 20, 2019
 

Task force to implement state plan to prevent, diagnose and manage chronic kidney disease.




Study links inflammatory marker to dementia

December 12, 2019
 

The marker called sCD14 is related to brain atrophy, cognitive decline and dementia.




Inflammatory marker linked to dementia

December 12, 2019
 

Elevated levels of marker associated with brain atrophy, decline in executive functions An inflammatory marker called sCD14 is related to brain atrophy, cognitive decline and dementia, according to a study of more than 4,700 participants from two large community-based heart studies. The study was published Dec. 9 in the journal Neurology. “We have strong reason […]



New drug targets leukemia, lymphoma

December 6, 2019
 

The class of drugs called PROTAC would treat T-cell malignancies such as T-cell acute leukemia and T-cell lymphoma.


Erase Cancer

Leukemia, lymphoma squarely in sights of new class of drugs

December 6, 2019
 

UT Health San Antonio researchers, working with collaborators at the University of Florida, have discovered a safe and potent next generation of drugs to fight multiple types of leukemia and lymphoma in adults and children. The journal Nature Medicine reported the findings Dec. 2. “This is a new class of drugs called PROTACs that target […]